We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Per- and polyfluoroalkyl substances concentrations are associated with an unfavorable cardio-metabolic risk profile: findings from two population-based cohort studies
Summary
Not relevant to microplastics — this epidemiological study from two European cohorts finds that blood levels of PFAS chemicals (PFOA, PFOS, PFHxS) are associated with an unfavorable lipid profile, with stronger effects in younger individuals, supporting calls for tighter PFAS regulation.
Abstract Per- and polyfluoroalkyl substances (PFAS) are widely used and persistent chemicals, leading to ubiquitous exposure. Although high PFAS levels have been associated with an adverse cardiovascular risk profile, the distribution of levels and relations with cardio-metabolic risk markers in the general population have not been fully characterized. We assessed the association between blood levels of perfluorooctaneic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorohexanesulfonic acid (PFHxS) and a range of lipoproteins and metabolites as well as clinical lipid measurements. We used data from participants of the Netherlands Epidemiology of Obesity study (NEO) (n= 584) and the Rhineland Study (n= 1,962), jointly spanning an age range of 30 to 89 years. PFAS were measured with the Metabolon HD4 platform, and lipoprotein and metabolite profiles were measured using Nightingale’s nuclear magnetic resonance-spectroscopy platform, and mainly comprised lipoprotein markers. Using linear regression analyses, we quantified age-, sex- and education-adjusted associations of PFOA, PFOS, and PFHxS with clinical lipid measurements and 224 lipoproteins and metabolites. Higher levels of PFAS, particularly PFOS and PFHxS, were associated with higher concentrations of total lipid, cholesterol and phospholipid content in most HDL, IDL, LDL and VLDL subclasses. The effect sizes were age-dependent for the majority of the associations, with the deleterious effects of PFAS being generally stronger in people below compared to those above median age. Our observation that in the general population even low PFAS concentrations are associated with an unfavorable lipid profile, calls for further critical regulation of PFAS substances.
Sign in to start a discussion.
More Papers Like This
Per- and Polyfluoroalkyl Substances Concentrations are Associated with an Unfavorable Cardio-Metabolic Risk Profile: Findings from Two Population-Based Cohort Studies
Researchers found that even low blood levels of PFAS ("forever chemicals") in the general population were associated with worse cholesterol and lipoprotein profiles — a known risk factor for heart disease — with stronger harmful effects in younger adults, supporting calls for stricter regulation of these persistent chemicals.
Per- and Polyfluoroalkyl Substances (PFAS) as Emerging Obesogens: Mechanisms, Epidemiological Evidence, and Regulatory Challenges
This review examines growing evidence that PFAS, the 'forever chemicals' found in many consumer products, may act as obesogens, meaning they could promote obesity by disrupting hormones and fat metabolism. PFAS exposure has been linked to changes in how the body stores fat and processes lipids, with some studies suggesting maternal exposure may increase obesity risk in children. While focused on PFAS rather than microplastics, the findings are relevant because both are persistent environmental pollutants that can act as endocrine disruptors.
Microplastics, nanoplastics, and plastic chemicals: applying the key characteristics of metabolism disrupting agents shows reason for concern
Researchers applied the key characteristics framework for metabolism-disrupting agents to evaluate plastic-derived chemicals and micro- and nanoplastic particles. The study suggests that common plastic chemicals such as perfluorinated compounds and plastic particles themselves meet criteria associated with metabolic disruption, raising concerns about their potential role in metabolic diseases.
Association between exposure to microplastics and lipid disorders: A case-control study
Researchers conducted a case-control study examining the association between internal microplastic exposure and lipid metabolism disorders. The study found that microplastic exposure was significantly associated with lipid disorders, providing novel evidence that microplastics may adversely affect lipid metabolism in humans.
Microplastic pollution: A potent threat for metabolic disruption in mammals
This review examines the evidence linking microplastic exposure to metabolic disruption, covering mechanisms by which microplastics and their associated chemical additives may interfere with hormonal regulation, glucose metabolism, and lipid homeostasis. The authors identify microplastics as a potent emerging threat to metabolic health.